Cargando…
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials
INTRODUCTION: Enrolling cancer patients in phase I clinical trials (P1s) requires that they fulfill specific criteria. Between the time they sign the consent form and the 1(st) administration of the experimental drug, some patients may be excluded and considered as screen failures (SFs). Our objecti...
Autores principales: | Kempf, Emmanuelle, Lemoine, Nathalie, Tergemina-Clain, Gabrielle, Turpin, Anthony, Postel-Vinay, Sophie, Lanoy, Emilie, Soria, Jean-Charles, Massard, Christophe, Hollebecque, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858154/ https://www.ncbi.nlm.nih.gov/pubmed/27149667 http://dx.doi.org/10.1371/journal.pone.0154895 |
Ejemplares similares
-
Patient-reported tolerability of adverse events in phase 1 trials
por: Henon, Clémence, et al.
Publicado: (2017) -
Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
por: Postel-Vinay, Sophie, et al.
Publicado: (2020) -
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
por: Watson, Sarah, et al.
Publicado: (2018) -
Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
por: Martin‐Romano, Patricia, et al.
Publicado: (2020) -
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)